Jeddoub Othmane, Touil Nadia, Nyabi Omar, El Fahime Elmostafa, Ennibi Khalid, Gala Jean-Luc, Benjouad Abdelaziz, Belayachi Lamiae
International Faculty of Medicine, Health Sciences Research Center, College of Health Sciences, International University of Rabat, Technopolis Parc, Rocade of Rabat-Salé, Sala-Al Jadida 11100, Morocco.
Unité de Recherche Biomédicale et Epidemiologie (URBE), Centre de Virologie, Maladies Infectieuses et Tropicales, Hopital Militaire d'Instruction Mohammed V, Faculté de Médecine et de Pharmacie de Rabat, Rabat 10100, Morocco.
Biosensors (Basel). 2025 Jun 12;15(6):379. doi: 10.3390/bios15060379.
Viral infections impose a significant burden on global public health and the economy. This study examines the current state of CRISPR-Cas system research, focusing on their applications in viral detection and their evolution over recent years. A bibliometric analysis and systematic review were conducted using articles published between 2019 and 2024, retrieved from Web of Science, Scopus, and PubMed databases. Out of 2713 identified articles, 194 were included in the analysis. The findings reveal substantial growth in scientific output related to CRISPR-Cas systems, with the United States leading in research and development in this field. The rapid increase in CRISPR-Cas research during this period underscores its immense potential to transform viral diagnostics. With advantages such as speed, precision, and suitability for deployment in resource-limited settings, CRISPR-Cas systems outperform many traditional diagnostic methods. The concerted efforts of scientists worldwide further highlight the promising future of this technology. CRISPR-Cas systems are emerging as a powerful alternative, offering the possibility of expedited and accessible point-of-care testing and paving the way for more equitable and effective diagnostics on a global scale.
病毒感染给全球公共卫生和经济带来了巨大负担。本研究考察了CRISPR-Cas系统的研究现状,重点关注其在病毒检测中的应用以及近年来的发展演变。使用从Web of Science、Scopus和PubMed数据库检索到的2019年至2024年发表的文章进行了文献计量分析和系统综述。在确定的2713篇文章中,有194篇纳入了分析。研究结果显示,与CRISPR-Cas系统相关的科研产出大幅增长,美国在该领域的研发中处于领先地位。这一时期CRISPR-Cas研究的迅速增加凸显了其在变革病毒诊断方面的巨大潜力。CRISPR-Cas系统具有速度快、精度高以及适合在资源有限的环境中部署等优势,优于许多传统诊断方法。全球科学家的共同努力进一步凸显了这项技术的光明前景。CRISPR-Cas系统正在成为一种强大的替代方案,为快速且便捷的即时检测提供了可能,并为在全球范围内实现更公平、有效的诊断铺平了道路。